Buy Tesamorelin Research Peptide

At 44 amino acids, Tesamorelin represents the longest and most structurally complex synthetic GHRH analogue routinely encountered in preclinical receptor pharmacology research. Also designated TH9507 (CAS 218949-48-5), the compound carries a molecular weight of 5134.66 g/mol. Its defining feature is an N-terminal trans-3-hexenoic acid modification investigated for its influence on metabolic stability and GHRHR engagement. Produced via solid-phase peptide synthesis.

In vitro assays using recombinant GHRHR-expressing cell lines have explored the compound's receptor binding affinity and cAMP generation relative to shorter GHRH fragments. In vivo rodent pharmacokinetic studies have characterised the degradation profile of Tesamorelin, investigating whether the hexenoic acid moiety confers measurable resistance to N-terminal enzymatic cleavage.

Manufactured in a cGMP compliant laboratory to a guaranteed purity of 98% or above. Every batch undergoes independent testing using HPLC and MS-UPLC analysis before dispatch. Vials are vacuum sealed and stored in a temperature controlled, monitored cold storage system. Certificates of Analysis are available on request.

Sold strictly for in vitro research purposes only. Not for human consumption. Intended for use by qualified researchers in laboratory settings only.